Condensed Balance Sheet (USD $)	Sep. 30, 2013
ASSETS
Cash	$ 65,503
Deferred offering costs	273,479
Total assets	338,982
LIABILITIES AND STOCKHOLDER’S EQUITY
Accrued offering costs	260,971
Note payable	55,000
Total liabilities	315,971
Stockholder's equity
Common stock, $.0001 par value, 50,000,000 shares authorized; 2,003,225 shares issued and outstanding	200
Additional paid-in capital	24,800
Deficit accumulated during the development stage	(1,989)
Total stockholder's equity	23,011
Total liabilities and stockholder's equity	$ 338,982